Annual CFF
$451.53 M
+$422.52 M+1456.25%
December 31, 2023
Summary
- As of February 12, 2025, GPCR annual cash flow from financing activities is $451.53 million, with the most recent change of +$422.52 million (+1456.25%) on December 31, 2023.
- During the last 3 years, GPCR annual CFF has risen by +$425.69 million (+1647.61%).
- GPCR annual CFF is now at all-time high.
Performance
GPCR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$757.00 K
-$515.46 M-100.15%
September 30, 2024
Summary
- As of February 12, 2025, GPCR quarterly cash flow from financing activities is -$757.00 thousand, with the most recent change of -$515.46 million (-100.15%) on September 30, 2024.
- Over the past year, GPCR quarterly CFF has dropped by -$1.23 million (-260.04%).
- GPCR quarterly CFF is now -100.15% below its all-time high of $514.70 million, reached on June 30, 2024.
Performance
GPCR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$796.28 M
-$1.23 M-0.15%
September 30, 2024
Summary
- As of February 12, 2025, GPCR TTM cash flow from financing activities is $796.28 million, with the most recent change of -$1.23 million (-0.15%) on September 30, 2024.
- Over the past year, GPCR TTM CFF has increased by +$626.69 million (+369.54%).
- GPCR TTM CFF is now -0.15% below its all-time high of $797.51 million, reached on June 30, 2024.
Performance
GPCR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GPCR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1456.3% | -260.0% | +369.5% |
| 3 y3 years | +1647.6% | -260.0% | +369.5% |
| 5 y5 years | +1647.6% | -260.0% | +369.5% |
GPCR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1456.3% | -100.2% | +47.7% | -0.1% | >+9999.0% |
| 5 y | 5-year | at high | +1647.6% | -100.2% | +47.7% | -0.1% | >+9999.0% |
| alltime | all time | at high | +1647.6% | -100.2% | +47.7% | -0.1% | >+9999.0% |
Structure Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$757.00 K(-100.1%) | $796.28 M(-0.2%) |
| Jun 2024 | - | $514.70 M(>+9900.0%) | $797.51 M(+182.3%) |
| Mar 2024 | - | $702.00 K(-99.8%) | $282.51 M(-37.4%) |
| Dec 2023 | $451.53 M | $281.63 M(>+9900.0%) | $451.53 M(+166.3%) |
| Sep 2023 | - | $473.00 K(-259.3%) | $169.59 M(+0.4%) |
| Jun 2023 | - | -$297.00 K(-100.2%) | $168.85 M(-15.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $169.73 M(<-9900.0%) | $200.19 M(+590.0%) |
| Dec 2022 | $29.01 M(-71.9%) | -$316.00 K(+22.0%) | $29.01 M(-1.1%) |
| Sep 2022 | - | -$259.00 K(-100.8%) | $29.33 M(-0.9%) |
| Jun 2022 | - | $31.04 M(-2243.4%) | $29.59 M(-2143.4%) |
| Mar 2022 | - | -$1.45 M | -$1.45 M |
| Dec 2021 | $103.25 M(+299.6%) | - | - |
| Dec 2020 | $25.84 M | - | - |
FAQ
- What is Structure Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Structure Therapeutics?
- What is Structure Therapeutics annual CFF year-on-year change?
- What is Structure Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Structure Therapeutics?
- What is Structure Therapeutics quarterly CFF year-on-year change?
- What is Structure Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Structure Therapeutics?
- What is Structure Therapeutics TTM CFF year-on-year change?
What is Structure Therapeutics annual cash flow from financing activities?
The current annual CFF of GPCR is $451.53 M
What is the all time high annual CFF for Structure Therapeutics?
Structure Therapeutics all-time high annual cash flow from financing activities is $451.53 M
What is Structure Therapeutics annual CFF year-on-year change?
Over the past year, GPCR annual cash flow from financing activities has changed by +$422.52 M (+1456.25%)
What is Structure Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of GPCR is -$757.00 K
What is the all time high quarterly CFF for Structure Therapeutics?
Structure Therapeutics all-time high quarterly cash flow from financing activities is $514.70 M
What is Structure Therapeutics quarterly CFF year-on-year change?
Over the past year, GPCR quarterly cash flow from financing activities has changed by -$1.23 M (-260.04%)
What is Structure Therapeutics TTM cash flow from financing activities?
The current TTM CFF of GPCR is $796.28 M
What is the all time high TTM CFF for Structure Therapeutics?
Structure Therapeutics all-time high TTM cash flow from financing activities is $797.51 M
What is Structure Therapeutics TTM CFF year-on-year change?
Over the past year, GPCR TTM cash flow from financing activities has changed by +$626.69 M (+369.54%)